Inventor
CARTER PAUL J
US39 patents
⚠️ This page may combine multiple inventors who share the name “CARTER PAUL J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GENENTECH INC
28 patentsUS7695936B2Apr 13, 2010
Knobs and holes heteromeric polypeptides
GENENTECH INC817 citations99
US7642228B2Jan 5, 2010
Method for making heteromultimeric polypeptides
GENENTECH INC404 citations99
US6800738B1Oct 5, 2004
Method for making humanized antibodies
GENENTECH INC274 citations99
US6719971B1Apr 13, 2004
Method for making humanized antibodies
GENENTECH INC393 citations99
US6639055B1Oct 28, 2003
Method for making humanized antibodies
GENENTECH INC523 citations99
US6407213B1Jun 18, 2002
Method for making humanized antibodies
GENENTECH INC2,158 citations99
US6054297AApr 25, 2000
Humanized antibodies and methods for making them
GENENTECH INC2,266 citations99
US5821337AOct 13, 1998
Immunoglobulin variants
GENENTECH INC4,043 citations99
US5821333AOct 13, 1998
Method for making heteromultimeric polypeptides
GENENTECH INC681 citations99
US5807706ASep 15, 1998
Method for making heteromultimeric polypeptides
GENENTECH INC587 citations99
US5731168AMar 24, 1998
Method for making heteromultimeric polypeptides
GENENTECH INC2,644 citations99
US5648237AJul 15, 1997
Expression of functional antibody fragments
GENENTECH INC1,530 citations99
US7951917B1May 31, 2011
Method for making multispecific antibodies having heteromultimeric and common components
GENENTECH INC186 citations98
US7288249B2Oct 30, 2007
Antibodies for cancer therapy and diagnosis
GENENTECH INC68 citations98
US7183076B2Feb 27, 2007
Method for making multispecific antibodies having heteromultimeric and common components
GENENTECH INC565 citations98
US7018809B1Mar 28, 2006
Expression of functional antibody fragments
GENENTECH INC116 citations98
US6342220B1Jan 29, 2002
Agonist antibodies
GENENTECH INC90 citations98
US7435797B2Oct 14, 2008
Anti-HER2 antibody variants
GENENTECH INC79 citations96
US7850966B2Dec 14, 2010
Method of treating breast cancer using anti-HER2 antibody variants
GENENTECH INC45 citations95
US6737249B1May 18, 2004
Agonist antibodies
GENENTECH INC16 citations84
US9409989B2Aug 9, 2016
Method for making multispecific antibodies having heteromultimeric and common components
GENENTECH INC13 citations83
US7524937B2Apr 28, 2009
WSX receptor agonist antibodies
GENENTECH INC15 citations79
US10323094B2Jun 18, 2019
Humanized and affinity matured antibodies to FcRH5 and methods of use
GENENTECH INC2 citations71
US12030947B2Jul 9, 2024
Humanized and affinity matured antibodies to FcRH5 and methods of use
GENENTECH INC0 citations61
US11192950B2Dec 7, 2021
Humanized and affinity matured antibodies to FcRH5 and methods of use
GENENTECH INC0 citations61
US12099064B2Sep 24, 2024
Anti-hypusine antibodies and uses thereof
GENENTECH INC0 citations57
US10877042B2Dec 29, 2020
Anti-hypusine antibodies and uses thereof
GENENTECH INC1 citations57
US10208120B2Feb 19, 2019
Anti-FGFR2/3 antibodies and methods using same
GENENTECH INC0 citations40